The Anti-HIV Pentameric Pseudopeptide HB-19 Binds the C-terminal End of Nucleolin and Prevents Anchorage of Virus Particles in the Plasma Membrane of Target Cells-Reference-Cited by-同舟云学术

The Anti-HIV Pentameric Pseudopeptide HB-19 Binds the C-terminal End of Nucleolin and Prevents Anchorage of Virus Particles in the Plasma Membrane of Target Cells

Published:2002-06 Issue:23 Volume:277 Page:20877-20886
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Nisole Sébastien,Said Elias A.,Mische Claudia,Prevost Marie-Christine,Krust Bernard,Bouvet Philippe,Bianco Alberto,Briand Jean-Paul,Hovanessian Ara G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. The HB-19 Pseudopeptide 5[Kpsi(CH2N)PR]-TASP Inhibits Attachment of T Lymphocyte- and Macrophage-Tropic HIV to Permissive Cells

2. HIV-1 attachment: another look

3. Identification of V3 Loop-binding Proteins as Potential Receptors Implicated in the Binding of HIV Particles to CD4+Cells

4. The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans

5. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLR4 TIR domain and nucleolin GAR domain synergistically mediate RSV infection and induce neuronal inflammatory damage in SH‐SY5Y cells;Journal of Medical Virology;2024-04

2. Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression;iScience;2024-01

3. Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome;Proceedings of the National Academy of Sciences;2023-11-28

4. Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression;2023-11-02

5. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review);International Journal of Molecular Medicine;2023-07-21